MANNKIND CORP (MNKD)

↓ Download CSV

CIK 0000899460 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, MANNKIND CORP reported revenue of $348.97M, up 22.2% from the prior year. The company was profitable, with a net margin of 1.7%. It held $792.18M in total assets against $843.20M in total liabilities.

Key ratios (FY2025)

11.1%
Operating margin
1.7%
Net margin
+22.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$348.97M$285.50M$198.96M$99.77M$75.44M$65.14M$63.04M$27.86M$11.74M$174.76M
Cost of Revenue$26.80M$17.43M$20.86M$16.00M$16.83M$15.08M$20.08M$19.39M$17.23M$17.12M
Operating Income$38.80M$72.59M$8.68M-$64.11M-$47.02M-$47.91M-$44.60M-$76.59M-$108.19M$67.26M
Net Income$5.86M$27.59M-$11.94M-$87.40M-$80.93M-$57.24M-$51.90M-$86.97M-$117.33M$125.66M
EPS (Diluted)$0.02$0.10$-0.04$-0.34$-0.32$-0.26$-0.60$-1.13$1.36
Total Assets$792.18M$393.84M$475.20M$295.28M$321.16M$108.61M$93.72M$107.70M$84.58M$107.06M
Total Liabilities$843.20M$472.66M$721.37M$545.82M$530.51M$289.03M$284.25M$282.79M$299.31M$290.66M
Shareholders' Equity-$51.02M-$78.82M-$246.17M-$250.54M-$209.35M-$180.42M-$190.53M-$175.08M-$214.73M-$183.59M
Cash & Equivalents$74.88M$46.34M$238.48M$69.77M$124.18M$67.00M$29.91M$71.16M$43.95M$22.89M
Operating Cash Flow$18.25M$42.51M$34.09M-$80.68M-$61.71M-$28.13M-$88.48M-$37.73M-$64.78M-$78.09M
Capital Expenditures$4.57M$9.69M$42.44M$7.59M$11.47M$801.0K$2.56M$354.0K$1.14M
Shares Outstanding307.83M302.96M270.03M263.79M251.48M242.12M211.79M187.03M119.05M95.68M